International Conference and Exhibition on Nanomedicine and Nanotechnology

Short Name: Nanomed Meeting 2017

Theme: Challenges and Innovations in next generation medicine

Dates: November 23-24, 2017

Venue: Dubai, UAE

 

Website: http://www.meetingsint.com/pharma-conferences/nanomedicine-nanotechnology

Registration Link: http://www.meetingsint.com/pharma-conferences/nanomedicine-nanotechnology/registration

Nanomed Meeting 2017 Organizing Committee invites you to attend the largest assemblage of Nanomedicine and Nanotechnology researchers from around the globe during November 23-24, 2017 at Dubai, UAE.

 

Nanomed Meeting 2017is a global annual event. This International Conference and Exhibition on Nanomedicine and Nanotechnology brings together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials and CROs from around the world. The passage of Nanomed Meeting 2017 through a decade at Asia finds much requirement for discussion also focusing the latest developments in the field of Nanomedicine and Nanotechnology.

 

Why to attend?

Join your peers around the world focused on learning about Nanomedicine and Nanotechnology related advances, which is your single best opportunity to reach the largest assemblage of participants from the Nanomedicine and Nanotechnology community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 2-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Nanomedicine and Nanotechnology are hallmarks of this conference.

 

Target Audience:

Directors, CEO’s of Organizations

Business Development Managers

Chief Scientific Officers

R&D Researchers from Nanomedicine and Nanotechnology Industries

Professors, Associate Professors, Assistant Professors

PhD Scholars

Patent Attorneys

Intellectual Property Attorneys

Investment Analysts

Association, Association presidents and professionals

Noble laureates in Health Care and Medicine

Nanomedicine Professionals

Molecular Nanotechnology Professionals

Software development companies

Research Institutes and members

Supply Chain companies

Manufacturing Companies

CRO and DATA management Companies

Training Institutes

Business Entrepreneurs

 

Audience Share:

Industry   60%

Academia   30%

Others     10%

 

Session/Tracks

 Track 1: Nanomedicine

Track 2: Nanoscience and Technology

Track 3: Molecular Nanotechnology

Track 4: Nanoparticles

Track 5: Advanced Nanomaterial’s

Track 6: Nanomedicine in Drug Delivery

Track 7: Nanotechnology in Tissue Engineering

Track 8: Nano pharmaceuticals

Track 9: Nanotechnology for Pediatric Medicine

Track 10: Nanotechnology in Healthcare

Track 11: Biomaterials and Medical Devices

Track 12: Recent Advances in Nanotechnology

Track 13: Major Challenges in Nanotechnology

 

Market Analysis

The new title on “Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," predicts that the total Nanomedicine market globally will be worth USD 177.60 billion by 2019, growing considerably from its 2012 value of USD 78.54 billion. This market is expected to achieve a compounded annual growth rate of 12.3% between 2013 and 2019.

 

The report talks about the major growth areas of within the Nanomedicine market over the period of forecast. The introduction of new technologies and applications in this sector will propel growth to a significant degree at the global level. Further, the initiatives taken by various governments as well as privately-funded institutions towards promoting the commercialization of new Nanomedicine products will boost this market. The report also dwells on the role played by the rising geriatric population base, the prevalence of medical needs that are in need of treatment, as well as the rising incidence of chronic diseases globally.

 

According to the report, the leading application segment within the Nanomedicine market was that of oncology, holding a 38% share of the overall market in 2012, as a vast number of commercially available products prevail in this sector.

 

The development of Nanomedicine-based treatments and products that are able to directly target tumors in the brain and other bodily sites is poised to be a significant factor affecting growth in this market.

 

Though the largest market segment within the Nanomedicine market is that of oncology, the fastest growing segment is the cardiovascular market. According to the Transparency Market Research report, growth in this segment has been fuelled by the presence of a sizeable patient population, and a simultaneous growth in the demand for device and drugs that are based on Nanomedicine. These factors are collectively anticipated to further fuel the growth of the cardiovascular segment within the Nanomedicine market.

 

The report also carries out an in-depth analysis of the regional market share based on the applications, revenue, and products. According to the report, the Nanomedicine market was largely dominated by North America in 2012. It is expected that this regional market will continue to hold its leading position in the way over the forecast period until 2019.

 

Though the larger market share will be held by North America, it is anticipated that the fastest growing market, by region, will be Asia-Pacific. The report states that the CAGR recorded by the Asia-Pacific market will be 14.6% between 2013 and 2019.

 

Furthermore, the analysis of the regional markets also concludes that the Europe region is predicted to show a growth rate that’s relatively higher than that of North America. Factors that are likely to cause this increased growth rate include: an improvement in the regulatory framework as well as the presence of a wide-ranging product portfolio in the pipeline, set to be introduced by leading market players.

 

The report on the global Nanomedicine market additionally comprises an overview of the key market players in a section dedicated to company profiles. These key market players include names such as: Abbott Laboratories, Merck & Co Inc, Pfizer Inc., GE Healthcare, Nanosphere Inc., and many more.

 

GLOBAL MARKET

The emergence of Nanomedicine and the application of nanomaterials in the healthcare industry will bring about groundbreaking improvements to the current therapeutic and diagnostic scenario. Some of the drivers of this market include increasing research funding, rising government support, improved regulatory framework, technological know-how and rising prevalence of chronic diseases such as diabetes, cancers, obesity, kidney disorders, orthopedic diseases and others.

 

The global Nanomedicine market is categorized into six segments on the basis of application, namely neurology, cardiovascular, anti-inflammatory, anti-infective, oncology and others.

 

Oncology held majority of the market share in 2012 on account of following factors:

 

Presence of high number of commercialized Nanomedicine products in the market

 

Improved bioavailability and efficacy of the tumor specific Nanomedicine enabling targeted drug delivery

 

Rise in Nanomedicine drug formulations replacing conventional drug formulations in cancer treatment

 

However, the global market for cardiovascular segment is expected to grow at the fastest pace owing to increasing prevalence of cardiovascular diseases demanding drugs with improved efficacy and therapeutic properties. Furthermore, realizing the importance and benefits of Nanomedicine, researchers and manufacturers are striving to develop products with improved therapeutic properties in the cardiovascular segment.

 

The North American Nanomedicine market held the majority of global market share in 2012 because of the rapidly growing Nanomedicine market in the Asia–Pacific, Latin American and African region, presence of large number of patented Nanomedicine products and favorable regulatory framework in the region.In addition, the presence of sophisticated healthcare infrastructure supports development of advanced products such as nano probes, nanorobots, monoclonal antibody based immunoassays and nanoparticle based imaging agents for early detection of diseases.

 

However, the Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in Nanomedicine research funding in emerging economies such as China, India and other economies in the region.China is expected to surpass the United States in terms of nanotechnology funding in the near future, which indicates the growth offered by this region.

 

About City

Dubai is the most populous city in the United Arab Emirates (UAE). It is located on the southeast coast of the Persian Gulf and is one of the seven emirates that make up the country. The city of Dubai is located on the emirate's northern coastline and heads up the Dubai-Sharjah-Ajman metropolitan area. Dubai is to host World Expo 2020. Dubai has emerged as a global city and business hub of the Middle East. It is also a major transport hub for passengers and cargo. By the 1960s, Dubai's economy was based on revenues from trade and, to a smaller extent, oil exploration concessions, but oil was not discovered until 1966. Oil revenue first started to flow in 1969. Dubai's oil revenue helped accelerate the early development of the city, but its reserves are limited and production levels are low: today, less than 5% of the emirate's revenue comes from oil. The emirate's Western-style model of business drives its economy with the Main revenues now coming from tourism, aviation, real estate, and financial services. Dubai has recently attracted world attention through many innovative large construction projects and sports events. At its foot lies Dubai Fountain, with jets and lights choreographed to music. On artificial islands just offshore is Atlantis, The Palm, a resort with water and marine-animal parks The city has become iconic for its skyscrapers and high-rise buildings, in particular the world's tallest Building, the Burj Khalifa. Dubai delivers a world class education and also immense job opportunities for well-educated students.

 

Drop us an email for Program enquiry.

nanomedicine@pharmameetings.com

Sponsors / Exhibiting / Advertising.

nanomedicine@pharmameetings.com

General Queries.

nanomedicine@pharmameetings.com